Austrian Doctor Reinstated

A doctor who falsified legal documents and failed to get approval for a clinical trial has been reinstated by an Austrian commission.

Written byTia Ghose
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

InnsbruckJEFF WILCOX, FLICKR

An Austrian commission has ordered the Medical University of Innsbruck to rehire a doctor who committed several ethical lapses.

Urologist Hans Strasser was dismissed from his post at the university after patients in his trial complained of problems. Strasser was testing a stem cell therapy for urinary continence, but many patients did not improve and some had their bladder seal closed. Several of those patients are now suing Strasser for grievous bodily harm.

The Austrian Agency for Health and Food Safety investigated and found that the trial was illegal. Strasser failed to get proper approval for the trial, did not inform his patients about the type of procedure they underwent, and may have forged documents, Nature reports. In addition, Strasser reportedly gave the unapproved treatment ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies